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INTRODUCTION 
Therapy or treatment is the attempted remediation of a 
health problem, usually following a diagnosis that will be 
of great use to the mankind. Gene therapy is the insertion, 
alteration, or removal of genes within an individual's cells 
and biological tissues to treat disease. Usually viruses are 
used as vectors to carry the foreign gene into the host. A 
major drawback of virus based gene therapy is the 
immunogenicity of the vectors. Not only could the vector 
provoke an immediate adverse reaction to itself, immune 
protection can develop over time to the extent that repeated 
administration of the viral vector becomes useless. Also 
this gene therapy may trigger an oncogene. Chemotherapy 
in the simplest sense is the treatment of an ailment by 
chemicals. An alternative approach is the direct transfer of 
the non-defective bioactive gene products, peptides or 
proteins in their native conformation1-2. Although the 
transferred agents will not persist to the same degree as 
nucleic acid based vectors, they should be able to persist 
for a sufficient length of time to have efficacy in the 
transient therapeutic window. Delivery of therapeutic 
proteins to cells has certain advantages over delivery of 
nucleic acid. Since these proteins can be selected to carry 
correct post-translational modifications if any (e.g. 
glycosylation , phosphorylation) and can be of the same 
origin as the host, they will be well tolerated by the hosts 
and should not induce any immunogenic reaction3-5.  
Drug delivery is the method or process of administering a 
pharmaceutical compound to achieve a therapeutic effect 
in humans or animals. Improved patient compliance is due 
to; reduced frequency of administration and reduced side 
effects is due to low dose. Current efforts in the area of 
drug delivery include the development of targeted delivery 
in which the drug is only active in the target area of the 
body (for example, in cancerous tissues) and sustained 
release formulations in which the drug is released over a 
period of time in a controlled manner from a formulation6.  
Niosomes or non-ionic surfactant vesicles are microscopic 
lamellar structures formed on admixture of non-ionic 
surfactant of the alkyl or dialkyl polyglycerol ether class 
and cholesterol with subsequent hydration in aqueous 
media. Niosomal drug delivery system used to increase the 
bioavailability of the drug. Hence in the present 
investigation prepare Niosomes with higher entrapment 
efficiency and to check the stability of Niosomes in 
different temperature and pH.   
MATERIALS AND METHODS 
Solubility analysis: Five mg of ampicillin was dissolved in 
10ml of distilled water. Initially  the  pH  was  7.2  after  
the  addition  of  ampicillin  the  pH  was  adjust  at  4-5. 
Since the pH of ampicillin is 4-5. The  proper  vertox  
should  be  done  for  the  dissolving  of  ampicillin. This 
was made as stock solution. The  stock  solution  was  
taken  in  different  concentrations  along  with  the  
distilled  water  and  made  upto  3ml. Absorbance value 
was calculated  using uv-spectrophotometer at 283nm. 
Screening  of  antibiotics using  ampicillin: 200ml  of  LB  
agar  medium  was  prepared  in  conical  flask  and  Petri  
plates  were  well  packed . Both  the  LB  agar  medium  
and  petri  plates  were  autoclaved  at  1210 C  for  15mins. 
After  the  autoclave , the  medium  was  allow  to  cool  in  
the  laminar  chamber . Then  the  medium  was  poured  
using  pour  plate  method  and  the  wells  were  made  
using  gel  puncture . The  drug  was  taken  into  the  wells  
at  different  concentrations . Plates were incubated at 370 
C for 24 hrs. As a result , the  zones  were  formed  and  its  
diameter  was  calculated . 
Niosome preparation: Solution of surfactants/lipids is 
prepared by dissolving both in organic solvent 
(chloroform). The organic solvent is removed by rotary 
flask evaporation/under reduced pressure leads to 
formation of drug surfactant/lipid film. The surfactant/lipid 
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film is then hydrated with aqueous solution of drug at 
temperature slightly above the phase transition temperature 
of surfactants used, for specified period of time (time of 
hydration) with constant mild shaking. 
Niosome  encapsulation  of  the   drug hand  shaking  
method: The  vesicles  in  the  round  bottomed  flask  gets  
evaporated . 10 ml  of  drug  sample  was  taken  in  a  
syringe .It  was  added  to  the  round  bottomed   flask  
containing  the  vesicles . The  addition  of  the  drug  was  
done  by  drop  by  drop  and  constant shaking  in  the  
water  bath  at  500 C . 
Determination of entrapment efficiency: Niosomes 
containing drug were separated from unentrapped drug by 
centrifugation. This purified niosomal dispersion was used 
for further studies.  The niosomal dispersions were 
centrifuged at 4500 rpm for 30 minutes and the decanted  
fluid  was  separated  from  the  sediment  material ( the  
niosomes  containing  the  entrapped drug). The separated 
niosomal suspension (1 ml) was disrupted using 3 ml 50% 
propanol for 5 min. which was then analyzed 
spectrophotometrically for drug concentration at  λmax  280  
nm  to  calculate  the  amount  of  entrapped  drug against 
50% propanol as blank.  The  percentage  of  entrapped 
drug was calculated by applying the following equation.   
% entrapment =Ae x100 / Ai, Where, Ae is the amount of 
entrapped drug and Ai is the initial amount drug in  the 
lipid phase.   
Stability studies: The  stability  studies  of  the  optimized  
niosomal  formulation  were  performed  at different  
conditions  of  temperature  and pH and the action of 
enzymes and its effect on  physical  characteristics  and 
drug  content  was  noted. 
 pH stability: The  niosomal dispersions  (1 mg  drug 
entrapped niosome /5ml of pH 7 phosphate buffer ) were 
kept in the air tight containers and stored at five different 
pH 3, 5, 7, 9, 11 for  2 hours  and  the samples  were  
withdrawn.The  supernatant were analyzed 
spectrophotometrically  at λmax 280 nm after  centrifugation 
with 4500 rpm for 30 minutes. 
In vitro drug release: A study was done on the release 
pattern of the drug from the niosomal formulations 
prepared by thin film hydration method. After  seperating  
the  unentrapped  drug,  the  niosomal suspension  
containing  drug  equivalent  to  drug content  was  
pipetted  into  the  dialysis  bag which was previously 
soaked and washed several times with distilled water.  This 
was placed in 100 ml of phosphate buffer saline (pH 7.4) 
and kept with constant agitation on a magnetic stirrer 
maintaining a temperature of 37 C.   Each periodical time 
the whole sample were withdrawn and same volume of 
fresh sample was replaced. Then the samples were assayed 
spectrophotometrically at 280 nm using medium as blank.  
The release was compared with pure drug solution. 
RESULTS AND DISCUSSION 
The development of a novel drug delivery system with 
great patience compliance to the pharmaceutical industry is 
of present need. Oral administration of drug would be the 
only way to achieve such patience compliance. Since oral 
delivery of drug will have many barriers to cross through, 
proper carrier is needed. Niosome would be such a carrier 
to surpass all problems that oral drug delivery confronts. 
To start with the standard values of Drug (Ampicillin) 
must be estimated to compare with later experimental 
values.  
The niosomal formulations were prepared by varying 
concentrations of surfactant, cholesterol and drug by hand 
shaking method. The various ratios of all niosomal 
formulations were taken for size analysis.  Measurement  
of  the  niosome  size  was  made  by  using  a  optical  
microscope. Before  to  determine  the  size  analysis, first  
we calculated  the correction  factor  using  stage 
micrometer and eye piece micrometer with microscope 
using 10 X magnification. Nice vesicular structures were 
seen. The vesicle size and size distribution values of 
various ratios of formulation were calculated using 45 X 
magnification. The diameter of niosomes was found to be 
in the range of 150-175 nm. To view it under still 
microscopic level, it was subjected to Scanning electron 
microscopy (Figure 1) to know the exact size and shape of 
niosomal formulations. Niosomes was found be mostly 
spherical and slightly elongated with size ranging around 
165nm. The vesicles were discrete and separate with no 
aggregation or agglomeration.   
Entrapment efficiency: The amount of drug entrapped was 
analyzed with standard entrapment efficiency method. The 
entrapment efficiency varied with different concentration 
of drug, solvent and surfactant.The entrapment showed 
around 55% in all formulations with highest of 59±2% in 
1:1:1+10 formulation (Surfactant: Cholesterol: Drug + 
Diethyl ether ). Since this entrapment will lead to good 
releasing of drug into the system, we went for invitro drug 
release.  
In vitro drug release: The membrane permeability system 
in different time intervals was considered to check the 
invitro release of drug.  The OD values measured was 
compared with the standard values to know the drug 
release. On estimating the drug release, the amount 
released seems to be high in first few minutes which 
decreased on proceeding time; until it reach the long time, 
its releasing increases gradually.   
Stability Studies: In order to measure its stability in human 
system ; the drug entrapped Niosomes was checked for 
stability at different temperatures wherein it showed very 
less leakage of drug at typical body temperature and stable 
at storage temperatures. Further to know the stability of 
Niosomes in the gastro intestinal tract, it was subjected to 
various pH conditions (Table 3) and the result showed it 
released very well in pH ≥7. This makes a clear point that 
it will release drug only in basic environment passing all 
barriers of acidic conditions. 
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Table 1: In vitro drug release analysis. 
S.no Samples Time 
(mins) 
O.D  at  
253nm 
1 1 15 0.356 
2 2 30 0.382 
3 3 45 0.435 
4 4 60 0.453 
5 5 75 0.823 
6 6 90 0.441 
7 7 105 0.481 
8 8 120 0.452 
9 9 135 0.442 
10 10 150 0.412 
 
Table 2: In vitro drug release between Time  vs  O.D. 
Time (mins) Absorbance % 
15 35.6 
30 38.2 
45 43.5 
60 45.3 
75 82.3 
90 44.1 
105 48.1 
120 45.2 
135 44.2 
150 41.2 
 
 
Table 3: pH stability of niosomes 
pH O.D. value 
(280nm) 
Drug 
released(mg) 
3 0.072 0.24 
5 0.092 0.31 
7 0.318 0.52 
9 0.121 0.43 
11 0.225 0.48 
 
 
Figure 1: Activity of ampicillin on Enterococcus. 
 
 
CONCLUSIONS 
The pharmaceutical industry still suffers in need of proper 
delivery system for drugs. Normally oral drug delivery 
confronts a lot of problems like lesser bioavailability of 
drugs. The delivery systems currently available have least 
bit of patience compliance making them uncomfortable 
with side effects. This led to the development of Niosomes 
for carrying drug into the system orally overcoming the 
barriers of gastro-intestinal tract. The formulations were 
showing satisfactory particle size, encapsulation efficiency 
and invitro release studies.   Niosomes offer  advantages  
over  other drug  carriers  with respect to ease of 
preparation, their capacity to carry large amount of drugs 
and biocompatibility. The results reveal that Niosomes are 
comparatively stable at storage temperature. The action of 
pH even did not show considerable effect on Niosomes 
and they release entrapped drug at basic pH.  Thus  on  the  
basis  of  studies  conducted  we  can  state  that  Niosomes  
possess great potential as protein delivery carriers orally. 
REFERENCE 
1. Ford K.G., Souberbielle B.E., Darling D and Farzaneh F. 
Protein transduction: an alternative to genetic intervention?. 
Gene Ther., 2001. 8:1-4.  
2. Dalkara, D., G. Zuber and Behr, J.P. Intracytoplasmic delivery 
of anionic proteins. Mol. Ther. 2004. 9: 964-969. 
3. Azmin M.N., Florence A.T., Handjani-Vila R.M., Stuart J.F.B., 
Vanlerberghe G., and Whittaker J.S. The effect of non-ionic 
surfactant vesicle (niosome) entrapment on the absorption and 
distribution of methotrexate in mice. J. Pharm. Pharmacol., 
1985.37: 237–242. 
4. Baillie A.J., Florence A.T., Hume L.R, Rogerson A., and 
Muirhead G.T. The preparation and properties of niosomes-non-
ionic surfactant vesicles. J. Pharm Pharmacol., 1985. 37 (12): 
863–868. 
5. Murdan S, Gregoriadis G, Florence AT.  Sorbitan 
monostearate/polysorbate 20  organogels containing niosomes: 
a delivery  vehicle for antigens? Eur J Pharm Sci, 
1999;8(3):177-186. 
6. Malhotra M and Jain NK. Niosomes as Drug Carriers. Indian 
Drugs, 1994. 31(3): 81-86. 
 
 
